Cargando…

ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure

We sought to investigate the association of single nucleotide polymorphisms (SNPs) of the genes involved in βAR signaling with the response of patients to βAR blockers. A total of 2403 hospitalized patients with chronic heart failure (HF) were enrolled in a multicenter observational study as the fir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jin, Li, Chenze, Song, Ying, Fan, Xiaohan, You, Ling, Tan, Lun, Xiao, Lei, Li, Qing, Ruan, Guoran, Hu, Senlin, Cui, Wei, Li, Zongzhe, Ni, Li, Chen, Chen, Woo, Anthony Yiu-Ho, Xiao, Rui-Ping, Wang, Dao Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198009/ https://www.ncbi.nlm.nih.gov/pubmed/30374408 http://dx.doi.org/10.1038/s41421-018-0058-6

Ejemplares similares

Genetic Polymorphisms in ADRB2 and ADRB1 Are Associated with Differential Survival in Heart Failure Patients Taking β-Blockers
por: Guerra, Leonardo A., et al.
Publicado: (2022)

Obesity is associated with the Arg389Gly ADRB1 but not with the Trp64Arg ADRB3 polymorphism in children from San Luis Potosí and León, México
por: Aradillas-García, Celia, et al.
Publicado: (2017)

Genetic risk scores to predict the prognosis of chronic heart failure patients in Chinese Han
por: Li, Shiyang, et al.
Publicado: (2019)

Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure
por: Kang, Sheng, et al.
Publicado: (2015)

The crosstalk of HDAC3, microRNA-18a and ADRB3 in the progression of heart failure
por: Na, Jingtao, et al.
Publicado: (2021)

ADRB2 Arg16Gly Polymorphism, Lung Function, and Mortality: Results from the Atherosclerosis Risk in Communities Study
por: Ferdinands, Jill M., et al.
Publicado: (2007)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Beta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure
por: Mansur, Alfredo José, et al.
Publicado: (2009)

A common variant of RIP3 promoter region is associated with poor prognosis in heart failure patients by influencing SOX17 binding
por: Hu, Dong, et al.
Publicado: (2019)

ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1
por: Daghestani, Maha, et al.
Publicado: (2018)

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)

The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis
por: Wang, Xi, et al.
Publicado: (2018)

The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy
por: Eijgenraam, Tim R., et al.
Publicado: (2020)

The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction
por: Xu, Xizhen, et al.
Publicado: (2019)

Erratum to “ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis”
por: Wang, Xi, et al.
Publicado: (2018)

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure
por: Zhang, Xiaojian, et al.
Publicado: (2016)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Yanagisawa, Satoshi, et al.
Publicado: (2010)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy
por: Eijgenraam, Tim R., et al.
Publicado: (2020)

Association of rs2070600 in advanced glycosylation end‐product specific receptor with prognosis of heart failure
por: Li, Shiyang, et al.
Publicado: (2020)

Association of Systemic Trimethyllysine With Heart Failure With Preserved Ejection Fraction and Cardiovascular Events
por: Wei, Haoran, et al.
Publicado: (2022)

Beta-blockers and 1-year clinical outcomes in hospitalized heart failure patients with atrial fibrillation
por: XING, Fu-Wei, et al.
Publicado: (2021)

Endothelial Sirtuin 3 Dictates Glucose Transport to Cardiomyocyte and Sensitizes Pressure Overload‐Induced Heart Failure
por: Zeng, Heng, et al.
Publicado: (2020)

Preparation and evaluation of an Arg-Gly-Asp-modified chitosan/hydroxyapatite scaffold for application in bone tissue engineering
por: CHEN, LIN, et al.
Publicado: (2015)

Inflammatory Cytokines, Immune Cells, and Organ Interactions in Heart Failure
por: Li, Huihui, et al.
Publicado: (2021)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

Angiotensin receptor blockers in heart failure after the ELITE II trial
por: Willenheimer, Ronnie
Publicado: (2000)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
por: Tobin, S. W., et al.
Publicado: (2017)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
por: Erickson, Marc, et al.
Publicado: (2021)

Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography
por: Jones, K. A., et al.
Publicado: (2022)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

Heart Failure and Multimorbidity in Asia
por: Ang, Nathalie, et al.
Publicado: (2023)

Assessing inflammation in Chinese subjects with subtypes of heart failure: an observational study of the Chinese PLA Hospital Heart Failure Registry
por: Liu, Bo-Han, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vh8lp63jak9u64mkihi15v0728